Difficult Decisions in Hepatobiliary and Pancreatic Surgery

An Evidence-Based Approach
1. Auflage 2016
ISBN: 978-3-319-27363-1
Verlag: Springer International Publishing

Buch, Englisch, 695 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 11878 g

Reihe: Difficult Decisions in Surgery: An Evidence-Based Approach

This book is part of a series covering surgical specialties.  The volumes are multi-authored, containing brief chapters, each of which are devoted to one or two specific questions or decisions within that specialty that are difficult or controversial.  The volumes are intended as a current and timely reference source for practicing surgeons, surgeons in training, and educators that describe the recommended ideal approach, rather than customary care, in selected clinical situations.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Matthews, Jeffrey B.

Millis, J. Michael

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gastroentereologie, Proktologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Gastrointestinale & Colorectale Chirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Evidenzbasierte Medizin (EbM)

Inhaltsverzeichnis

Chapter 1: Finding and appraising the evidence: EBM and GRADEChapter 2: Is Surgery Indicated for Asymptomatic Giant Hepatic Hemangioma?Chapter 3: What is the Best Surgical Method of Addressing Hepatic Hemangiomas?Chapter 4: Which Diagnostic Modality is Best to Assess Benign Hepatic Tumors?Chapter 5: Cystic Diseases of the LiverChapter 6: When Should You Operate on Major Hepatic Trauma? Chapter 7: Surgical Treatment of Hepatocellular Carcinoma: Resection versus Transplantation Chapter 8: Hepatic Epithelioid HemangioendotheliomaChapter 9: What is the Best Way to Screen Cirrhotic Patients for Hepatocellular Carcinoma in the United States?Chapter 10: When is Laparoscopic Liver Resection Preferred Over Open Resection?Chapter 11: Clinical Management of Pyogenic Liver Abscesses Chapter 12: Which is better local therapy for HCC, RFA or TACE? Chapter 13: When should patients withliver metastases from colorectal cancer receive chemotherapy?  Chapter 14: What is the best way to assess hepatic reserve prior to liver resection in the cirrhotic patient?Chapter 15: Treatment Protocols for Small Hepatocellular Carcinoma (= 3cm): RFA or Resection?Chapter 16: Which is the Better Predictor of Hepatic Reserve Prior to Liver Resection:  MELD or the Child-Pugh Score?C hapter 17: Early (<24 hr) or Delayed Cholecystectomy for Acute Cholecystitis? Chapter 18: Primary Closure or T-tube Drainage after Open or Laparoscopic Common Bile Duct Exploration?Chapter 19: Single-Incision or Multiport Laparoscopic CholecystectomyChapter 20: Management of Recurrent CholangitisChapter 21: Management of postoperative bile duct stricture Chapter 22: Immediate or Delayed Repair for Bile Duct Injury Recognized Postoperatively?Chapter 23: Management of Suspected Choledocholithiasis on Intraoperative CholangiographyChapter 24: Management of Incidentally Discovered Gallbladder CancerChapter 25: Gallstone IleusChapter 26: Surgery or Endoscopy for Bile Duct Strictures secondary to Chronic Pancreatitis?Chapter 27: Routine or Selective Cholangiography for Elective Laparoscopic Cholecystectomy? Chapter 28: When is bile duct resection indicated for biliary strictures in primary sclerosing cholangitis?Chapter 29: Assessment of Bile Duct Tumors: Endoscopic vs RadiographicChapter 30: Management of Significant Hemobilia: Hepatic Artery Embolization or Stenting?Chapter 31: The assessment of ductal margin in curative-intent surgery for perihilar CholangiocarcinomaChapter 32: Management of early post-transplant portal vein thrombosis: results of interventional techniques versus surgicalChapter 33: When should patients with bleeding esophageal varices undergo TIPS versus endoscopic therapy?Chapter 34: Management of symptomatic portal hypertension: TIPS vs. medical managementChapter 35: Should all hepatic arteriovenous fistulas be embolized?Chapter 36: Early or Delayed Cholecystectomy in Acute Gallstone PancreatitisChapter 37: Nutritional Support in Acute Necrotizing PancreatitisChapter 38: Management of Symptomatic Pancreatic Pseudocyst Chapter 39: Antibiotic Prophylaxis for Acute Necrotizing PancreatitisChapter 40: Endoscopic or Minimally Invasive Debridement of Walled-off Pancreatic Necrosis?Chapter 41: Surgical Debridement in Necrotizing PancreatitisChapter 42: Surgery or Endotherapy for Large Duct Chronic Pancreatitis Chapter 43: Pancreatic Head Resection for Painful Chronic Pancreatitis Chapter 44: Is total pancreatectomy with islet autotransplantation indicated in hereditary/genetic pancreatitis?Chapter 45:  Management of Blunt Pancreatic Trauma in ChildrenChapter 46: Surgery or Surveillance for Asymptomatic Small Mucinous Pancreatic Head CystChapter 47: Management of Asymptomatic IPMN in the ElderlyChapter 48: Minimally Invasive Surgery for Pancreatic Head CancerChapter 49: Advanced Pancreatic Cancer Discovered at Operation: The Role of Palliative BypassChapter 50: Neoadjuvant Therapy for Borderline Resectable Pancreatic Head CancerChapter 51: Neoadjuvant Therapy for Resectable Pancreatic AdenocarcinomaChapter 52: Management of borderline resectable pancreatic cancerChapter 53: Peritoneal Drain Placement at PancreatoduodenectomyChapter 54: Management of Villous Adenoma of the Ampulla of VaterChapter 55: Splenic Preservation at Distal PancreatectomyChapter 56: Management of Small Nonfunctional Pancreatic Neuroendocrine TumorsChapter 57: Management of Pancreatic GastrinomaChapter 58: Management of Pancreatic Cancer in the Elderly